IWIN
EURONEXT:IWIN
Irwin Naturals Inc.
- Stock
Market Cap
107.23M
Beta: -
PE Ratio
−0.02
PFCF: −0.07
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|
average inventory | 16.61M - | 20.58M 23.86% | |||
average payables | 4.77M - | 7.12M 49.16% | |||
average receivables | 17.04M - | 19.14M 12.34% | |||
book value per share | 15.65 - | 12.13 22.50% | 12.07 0.48% | 16.21 34.29% | |
capex per share | -0.04 - | -0.11 197.03% | -0.04 61.36% | -0.10 141.65% | |
capex to depreciation | -0.04 - | -0.10 119.46% | -0.04 62.53% | -0.08 127.91% | |
capex to operating cash flow | -0.01 - | -0.02 49.57% | -0.00 71.45% | 0.02 596.01% | |
capex to revenue | -0.00 - | -0.00 256.02% | -0.00 66.10% | -0.00 223.26% | |
cash per share | 0.37 - | 0.36 2.29% | 0.52 43.78% | 0.56 7.14% | |
days of inventory on hand | 145.65 - | 100.62 30.91% | 122.34 21.58% | 168.59 37.80% | |
days payables outstanding | 43.20 - | 24.28 43.78% | 39.52 62.73% | 61.49 55.60% | |
days sales outstanding | 65.40 - | 71.08 8.69% | 60.62 14.71% | 88.16 45.42% | |
debt to assets | 0.26 - | 0.21 20.21% | 0.27 28.08% | ||
debt to equity | 0.65 - | 0.69 5.52% | 0.92 33.44% | ||
dividend yield | 2.77 - | 2.64 4.58% | 2.13 19.53% | ||
earnings yield | 2.80 - | 2.75 1.63% | 2.27 17.43% | -0.68 129.70% | |
enterprise value | 1.74M - | 11.83M 578.85% | 13.14M 11.06% | 24.26M 84.58% | |
enterprise value over ebitda | 0.27 - | 1.31 390.27% | 1.10 16.49% | 7.71 603.94% | |
ev to operating cash flow | 0.51 - | 1.44 180.36% | 1.20 16.68% | -3.81 417.64% | |
ev to sales | 0.02 - | 0.13 567.34% | 0.13 1.07% | 0.27 107.01% | |
free cash flow per share | 3.36 - | 6.64 97.50% | 9.09 36.93% | -4.55 150.08% | |
free cash flow yield | 1.59 - | 3.07 93.54% | 2.88 6.40% | -1.74 160.65% | |
graham net net | -4.41 - | -0.71 83.92% | -1.38 94.05% | -14.14 927.36% | |
graham number | 45.65 - | 40.27 11.79% | 44.15 9.65% | 25.34 42.61% | |
income quality | 0.57 - | 1.14 97.82% | 1.08 4.58% | 2.53 133.23% | |
intangibles to total assets | 0.00 - | 0.00 15.23% | 0.00 22.87% | 0.23 12,223.23% | |
interest coverage | 24.54 - | 80.69 228.73% | 1.75 97.83% | ||
interest debt per share | 8.17 - | 8.42 3.06% | 15.44 83.24% | ||
inventory turnover | 2.51 - | 3.63 44.75% | 2.98 17.75% | 2.17 27.43% | |
invested capital | 0.65 - | 0.69 5.52% | 0.92 33.44% | ||
market cap | 2.11M - | 2.63M 24.42% | 3.79M 44.11% | 3.73M 1.52% | |
net current asset value | 10.68M - | 12.24M 14.63% | 13.04M 6.52% | -949K 107.28% | |
net debt to ebitda | -0.06 - | 1.02 1,891.69% | 0.78 23.60% | 6.53 737.04% | |
net income per share | 5.92 - | 5.94 0.39% | 7.18 20.80% | -1.76 124.52% | |
operating cash flow per share | 3.40 - | 6.75 98.59% | 9.13 35.33% | -4.45 148.72% | |
payables turnover | 8.45 - | 15.03 77.87% | 9.24 38.55% | 5.94 35.73% | |
receivables turnover | 5.58 - | 5.13 8.00% | 6.02 17.25% | 4.14 31.23% | |
research and ddevelopement to revenue | |||||
return on tangible assets | 0.14 - | 0.20 41.08% | 0.18 8.27% | -0.04 122.63% | |
revenue per share | 87.94 - | 73.37 16.57% | 83.62 13.97% | 62.51 25.25% | |
roe | 0.38 - | 0.49 29.53% | 0.59 21.38% | -0.11 118.26% | |
roic | 0.40 - | 0.28 28.82% | 0.48 68.17% | 0.07 85.07% | |
sales general and administrative to revenue | |||||
shareholders equity per share | 15.65 - | 12.13 22.50% | 12.07 0.48% | 16.21 34.29% | |
stock based compensation to revenue | 0.02 - | 0.03 91.95% | |||
tangible asset value | 15.54M - | 14.69M 5.53% | 23.03M 56.82% | 12.41M 46.11% | |
tangible book value per share | 15.56 - | 12.05 22.52% | 19.19 59.20% | 8.67 54.82% | |
working capital | 12.82M - | 13.05M 1.78% | 15.47M 18.55% | 9.21M 40.44% |
All numbers in (except ratios and percentages)